|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.02 CNY | +1.26% |
|
+3.90% | +2.22% |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 550.36 million compared to CNY 472.18 million a year ago. Net income was CNY 117.99 million compared to CNY 75.04 million a year ago.
Basic earnings per share from continuing operations was CNY 0.4714 compared to CNY 0.3419 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.22% | 998M | |
| -4.86% | 2.97B | |
| -3.48% | 1.9B | |
| +0.51% | 1.84B | |
| -0.18% | 1.17B | |
| -11.03% | 1.07B | |
| +12.53% | 910M | |
| -8.80% | 904M | |
| -0.09% | 902M | |
| +3.50% | 826M |
SHANDONG BAILONG CHUANGYUAN BIO-TECH CO., LTD. 
